首页 | 本学科首页   官方微博 | 高级检索  
检索        

内镜下黏膜剥离术治疗结直肠黏膜内癌及癌前病变的有效性及安全性分析
引用本文:都超群,袁文照,赵明巍,贾伟,糜娇,袁宇迪,胡晓慧.内镜下黏膜剥离术治疗结直肠黏膜内癌及癌前病变的有效性及安全性分析[J].中国内镜杂志,2019,25(2):73-77.
作者姓名:都超群  袁文照  赵明巍  贾伟  糜娇  袁宇迪  胡晓慧
作者单位:(内蒙古自治区鄂尔多斯市中心医院康巴什部 消化科,内蒙古 鄂尔多斯市康巴什新区 017010)
摘    要:目的探讨内镜黏膜下剥离术(ESD)治疗结直肠黏膜内癌及癌前病变的有效性及安全性。方法回顾性分析该院2016年6月-2018年2月收治的25例结直肠黏膜内癌及癌前病变行ESD治疗的患者资料,评价ESD手术的安全性和疗效。结果 25例结直肠黏膜内癌及癌前病变,病灶大小1.1~6.9 cm,平均3.2 cm,手术时间35~240 min,平均85 min,一次性完整切除病灶21例,完整切除率为84.0%(21/25),3例病变部分剥离后高频电圈套器分次切除,1次术中出血转外科手术。所有病例术中均未发生穿孔,2例发生术后迟发性出血,再次内镜止血成功。所有ESD患者术后3个月复查,创面愈合率达100.0%,平均随访半年,局部无残留或复发。结论 ESD治疗结直肠黏膜内癌及癌前病变有较好的疗效和安全性,能实现较大病变的完整切除,术后复发率低,并发症相对较少,值得基层医院推广应用。

关 键 词:关键词:  结直肠黏膜内癌  黏膜剥离术  癌前病变  疗效
收稿时间:2018/6/19 0:00:00

Endoscopic subcucosal dissection in treatment of colorectal carcinoma in situ and precancerous lesions
Chao-qun Du,Wen-zhao Yuan,Ming-wei Zhao,Wei Ji,Jiao Mi,Yu-di Yuan,Xiao-hui Hu.Endoscopic subcucosal dissection in treatment of colorectal carcinoma in situ and precancerous lesions[J].China Journal of Endoscopy,2019,25(2):73-77.
Authors:Chao-qun Du  Wen-zhao Yuan  Ming-wei Zhao  Wei Ji  Jiao Mi  Yu-di Yuan  Xiao-hui Hu
Institution:(Department of Gastroenterology, Central Hospital, Erdos Kang Bashi, Inner Mongolia 017010, China)
Abstract:Abstract: Objective To investigate the efficacy and safety of endoscopic subcucosal dissection (ESD) in treatment of colorectal carcinoma in situ and precancerous lesions. Methods The data of 25 patients with colorectal carcinoma in situ and precancerous lesions who were treated with ESD from June 2016 to February 2018 was analyzed and evaluated the safety and efficacy of ESD. Results 25 cases of carcinoma in situ and precancerous lesions ranged from 1.1 ~ 6.9 cm in size with an average of 3.2 cm, and the operation time was 35 ~ 240 minutes with an average of 85 minutes. One-time complete resection of lesions was performed in 21 patients and the complete resection rate was 84.0% (21/25). 3 cases of high-frequency electrical snares were removed by fractionation, and 1 case of intraoperative hemorrhage was transferred to surgery. No perforation occurred in all these cases, delayed bleeding occurred in 2 cases, and endoscopic hemostasis was successful. All these patients were followed up for 3 months and the wound healing rate was 100.0%. The average follow-up period was 6 months and there was no residual or recurrence locally. Conclution ESD is a safe and effective treatment for the treatment of colorectal carcinoma in situ and precancerous lesions, which is worth clinical extension.
Keywords:Keywords: colorectal intramucosal carcinoma  mucosal dissection  precancerous lesion  efficacy
本文献已被 CNKI 等数据库收录!
点击此处可从《中国内镜杂志》浏览原始摘要信息
点击此处可从《中国内镜杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号